Physician profile
Brent Devries
NPI 1588667323
$2,041.36
in general payments reported to CMS, 2019-2025
26 companies · $316 in 2025
The $316 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $634 · 2020: $312 · 2022: $69.01 · 2023: $204 · 2024: $506 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,026.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,026.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $354.05 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $167.96 | 2019-2024 | Xarelto |
| Sanofi-Aventis U.S. LLC | $166.66 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $160.09 | 2019-2025 | Farxiga, Lokelma, Wainua |
| Pfizer INC. | $127.31 | 2019-2024 | |
| Abiomed | $125.00 | 2024 | Impella |
| Amgen INC. | $109.31 | 2019-2024 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $88.43 | 2019-2023 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $85.13 | 2019-2025 | Eliquis, Camzyos |
| Boston Scientific Corporation | $81.62 | 2023-2025 | Watchman Flx, Watchman, Cds - Mct/Cem Monitoring |
| Novo Nordisk INC | $78.62 | 2024-2025 | Wegovy |
| Esperion Therapeutics, INC. | $73.00 | 2020-2025 | Nexletol |
| Amarin Pharma, INC. | $70.14 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $69.18 | 2024-2025 | Onpattro |
| Lexicon Pharmaceuticals, INC. | $68.38 | 2023-2024 | Inpefa |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $35.61 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.99 | 2025 | |
| Kestra Medical Technology Services, INC. | $21.37 | 2023 | Assure Wcd |
| Inspire Medical Systems, INC. | $20.32 | 2023 | Inspire |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.02 | 2025 | Lifevest |
| Kiniksa Pharmaceuticals International, Plc | $15.88 | 2024 | Arcalyst |
| Philips North America LLC | $15.82 | 2025 | Ecc Solutions |
| Kowa Pharmaceuticals America, INC. | $14.73 | 2019 | |
| Scpharmaceuticals INC. | $14.45 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $13.48 | 2019 | |
| Gilead Sciences, INC. | $11.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brent Devries listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.